Healius Limited Stock

Equities

HLS

AU0000033359

Healthcare Facilities & Services

Market Closed - Australian S.E. 02:11:03 2024-06-07 am EDT 5-day change 1st Jan Change
1.35 AUD -1.82% Intraday chart for Healius Limited +6.30% -17.43%
Sales 2024 * 1.72B 1.13B Sales 2025 * 1.8B 1.18B Capitalization 980M 645M
Net income 2024 * -630M -415M Net income 2025 * 26M 17.11M EV / Sales 2024 * 1.44 x
Net Debt 2024 * 1.49B 980M Net Debt 2025 * 1.42B 934M EV / Sales 2025 * 1.33 x
P/E ratio 2024 *
-1.67 x
P/E ratio 2025 *
33.3 x
Employees 10,500
Yield 2024 *
-
Yield 2025 *
1.62%
Free-Float 87.61%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.82%
1 week+6.30%
Current month+6.30%
1 month+5.47%
3 months+1.12%
6 months-12.90%
Current year-17.43%
More quotes
1 week
1.28
Extreme 1.28
1.41
1 month
1.17
Extreme 1.167
1.41
Current year
1.08
Extreme 1.08
1.70
1 year
1.08
Extreme 1.08
3.27
3 years
1.08
Extreme 1.08
5.54
5 years
1.08
Extreme 1.08
5.54
10 years
1.08
Extreme 1.08
5.54
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23-02-28
Director of Finance/CFO - 20-01-31
Chief Tech/Sci/R&D Officer - 21-03-31
Members of the board TitleAgeSince
Director/Board Member 67 15-08-02
Chairman 65 21-02-24
Director/Board Member - 22-03-30
More insiders
Date Price Change Volume
24-06-07 1.35 -1.82% 2,341,103
24-06-06 1.375 +3.38% 2,758,930
24-06-05 1.33 +0.38% 2,623,986
24-06-04 1.325 -0.38% 2,639,125
24-06-03 1.33 +4.72% 2,896,686

Delayed Quote Australian S.E., June 07, 2024 at 02:11 am EDT

More quotes
Healius Limited is a healthcare company. The Company’s segments include Pathology, Imaging and Other. The Pathology segment is a provider of pathology services, including specialty pathology and clinical trials. The Imaging segment provides imaging services from standalone imaging sites, hospitals and medical centers. It has a network of pathology laboratories, collection centers and diagnostic imaging centers. It provides specialty diagnostic services to consumers and their referring practitioners. Its brands include Laverty Pathology, QML Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostics, Abbott Pathology, IQ Pathology, Vetnostics, TML Vetnostics, Agilex Biolabs, Lumus Imaging, and others. Its Pathology operates 100 medical laboratories and 2,000 patient collection centers across metropolitan, regional and remote Australia. IQ Pathology is a specialized dermatopathology laboratory that provides comprehensive dermatopathology services Australia wide.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
13
Last Close Price
1.35 AUD
Average target price
1.372 AUD
Spread / Average Target
+1.62%
Consensus